Researchers from the US will use the funds to create tech for those with spinal cord injuries and other debilitating conditions.
Patients needing surgery to reconstruct body parts such as noses and ears could soon have treatment using cartilage which has been grown in a lab.
The process involves growing someone’s cells in an incubator and then mixing them with a liquid which is 3D printed into the jelly-like shape needed.
It is then put back in an incubator to grow again until it is ready.
Three research groups, working independently of one another, reported in the journal Science on Thursday that they had used the Crispr-Cas9 technique to treat mice with a defective dystrophin gene. Each group loaded the DNA-cutting system onto a virus that infected the mice’s muscle cells, and excised from the gene a defective stretch of DNA known as an exon.
Without the defective exon, the muscle cells made a shortened dystrophin protein that was nonetheless functional, giving all of the mice more strength.
The teams were led by Charles A. Gersbach of Duke University, Eric N. Olson of the University of Texas Southwestern Medical Center and Amy J. Wagers of Harvard University.
Mosquito-borne disease affecting millions has had no approved vaccine until now
When female Aedes Aegypti mosquito sups on the blood of its human victims it too often deposits the virus that causes dengue, causing as many as 400 million infections per year worldwide. Severe forms of the painful, flu-like disease can be fatal, especially among children. And until recently there has been no truly effective prevention except avoiding getting bit. But the outlook against the disease is looking better.
During the past month Dengvaxia, developed by the French pharmaceutical company Sanofi, has been approved for use in three countries: Mexico and the Philippines approved the vaccine earlier this month. This week, the company also announced the drug has received the green light in Brazil, which has seen more than 1.4 million cases of the disease in 2015. Exactly when the inoculations will be deployed—and at what price—remains unclear as terms of the vaccine are being negotiated between the company and the countries.
It’s a new resin.
Researchers at Panasonic PCRFY −0.78% in Japan have developed a new kind of resin that has the potential to make personal health electronics leaner and comfier.
The stretchy tech, announced by the company on Dec. 28, can be used as a base for electronic materials. Its physical properties makes electronics easier to apply to skin or clothing—like a Band-Aid or a tattoo, rather than a watch or a strap.
Artificial intelligence is moving so fast that within a decade, we will even be able to swallow computers so they can perform internal operations and release drugs.
It is now possible to detect just one molecule of a substance, and we can detect said substance whether it is a solid, liquid, or gas.
Over the next few weeks, while browsing cuties on the dating app, Tinder, you may find an image of a celebrity with an ‘organ donor’ icon next to their photo. By swiping right (usually an action which means “sexy!”), you will be given the option to register as an organ donor.
In what might seem an unlikely partnership, Tinder has partnered with the UK’s National Health Service (NHS) to recruit organ donors.
Continue reading “Printable Organs Are Closer Than Ever Thanks to Three Bioprinting Breakthroughs” »
VetiGel: A way to instantly stop bleeding.
A 17-year-old invented an ingenious way to instantly stop bleeding.
Samsung’s already wide product family is getting even bigger thanks to its new chip dubbed the “Samsung Bio-Processor.” As the company tells it, it’s already in mass production and is “specifically designed to allow accelerated development of innovative wearable products for consumers who are increasingly monitoring their health and fitness on a daily basis.” Phew. The announcement post goes on to say that the processor is the first all-in-one health solution chip and that since it’s packing a number of different control and sensor units (like a quintet of Analog Front Ends, a microcontroller unit, digital signal processor and eFlash memory) it can do all these tricks without the need for external processing.
The idea behind the silicon is to be the one-stop wearable fitness resource. Those five AFEs? One keeps track of bioelectrical impedance analysis, while the others focus on volumetric measurements of organs, an electrocardiogram and skin temperature, among other things. Bear in mind that Samsung’s latest smartwatch, the Gear S2, only tracks your heart rate. Same goes for the Apple Watch. Considering how err… interesting Samsung wearables tend to be, a possible scenario here is that the tech giant won’t keep the Bio-Processor all to itself. Nope, the real money here lies in potentially licensing it out to other folks, as it’s wont to do with its other self-made parts.
We won’t have to wait too long to see these in the wild, either: Samsung promises it’ll be packed into devices available early next year. If you’re wondering where, the inevitable follow-up to the aforementioned Gear S2 successor is a pretty likely bet. Whether that shows its face at CES or Mobile World Congress is the real question, though.
